Gregori Casals

Grup de recerca

Segueix-lo/a a:

THERANANO: Determining the therapeutic use in liver diseases of advanced antioxidant conjugates based on cerium oxide nanoparticles

Investigador/a principal: Gregori Casals Mercadal

Finançador: Instituto de Salud Carlos III (Spain) (Programa financiador competitivo)

Codi: PI19/0074

Durada: 01/01/2020 - 31/12/2022
Evaluation of antioxidant and anti-inflammatory properties of cerium oxide nanoparticles as novel therapeutic strategy in hepatic steatosis.

Investigador/a principal: Gregori Casals Mercadal

Finançador: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede o evento); Fondo de Investigación Sanitaria

Durada: 01/01/2016 - 01/01/2018
Cerium oxide nanoparticles as a new therapeutic tool for tissue regeneration in liver diseases

Investigador/a principal: Víctor Franco Puntes

Durada: 01/01/2013 - 01/01/2015
Basic and translational implications of the functional and molecular alterations of the hepatic endothelium in cirrhosis

Investigador/a principal: Manuel Morales Ruiz

Durada: 01/01/2011 - 01/01/2013
Pathophysiological role of activated liver endothelial cells in cirrhosis. Possible therapeutical implications

Investigador/a principal: Manuel Morales Ruiz

Durada: 01/01/2008 - 01/01/2010